C4 Therapeutics Inc (CCCC) — Strategic Asset Allocation Index
C4 Therapeutics Inc (CCCC) has a Strategic Asset Allocation Index of 13.9% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $32.60 Million) total $32.60 Million, measured against net assets of $234.25 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check C4 Therapeutics Inc (CCCC) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
C4 Therapeutics Inc Strategic Asset Allocation Index (2020–2025)
This chart shows how C4 Therapeutics Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the index stands at 13.9%, representing strategic assets of $32.60 Million against net assets of $234.25 Million USD. See C4 Therapeutics Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for C4 Therapeutics Inc (2020–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for C4 Therapeutics Inc from 2020 to 2025, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see CCCC stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 18.9% | $48.56 Million | $- | $48.56 Million | $256.59 Million | ▲ +8.6 pp |
| 2024 | 10.4% | $22.36 Million | $- | $22.36 Million | $215.99 Million | ▼ -1.0 pp |
| 2023 | 11.4% | $28.01 Million | $- | $28.01 Million | $246.11 Million | ▼ -12.3 pp |
| 2022 | 23.6% | $68.36 Million | $7.40 Million | $60.96 Million | $289.23 Million | ▼ -13.7 pp |
| 2021 | 37.3% | $145.31 Million | $3.11 Million | $142.20 Million | $389.61 Million | ▲ +31.4 pp |
| 2020 | 5.9% | $16.55 Million | $16.55 Million | $0.00 | $280.79 Million | — |